• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

组蛋白 H3 赖氨酸过度甲基化是患者来源异种移植(PDX)小鼠模型中三种主要软组织肉瘤的常见分子改变。

Over-methylation of Histone H3 Lysines Is a Common Molecular Change Among the Three Major Types of Soft-tissue Sarcoma in Patient-derived Xenograft (PDX) Mouse Models.

机构信息

AntiCancer Inc, San Diego, CA, U.S.A.

Department of Surgery, University of California San Diego, La Jolla, CA, U.S.A.

出版信息

Cancer Genomics Proteomics. 2021 Nov-Dec;18(6):715-721. doi: 10.21873/cgp.20292.

DOI:10.21873/cgp.20292
PMID:34697064
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8569816/
Abstract

BACKGROUND/AIM: Sarcomas are considered a heterogeneous disease with incomplete understanding of its molecular basis. In the present study, to further understand general molecular changes in sarcoma, patient-derived xenograft (PDX) mouse models of the three most common soft-tissue sarcomas: myxofibrosarcoma, undifferentiated pleomorphic sarcoma (UPS) and liposarcoma were established and the methylation status of histone H3 lysine marks was studied.

MATERIALS AND METHODS

Immunoblotting and immunohistochemical staining were used to quantify the extent of methylation of histone H3K4me3 and histone H3K9me3.

RESULTS

In all 3 sarcoma types in PDX models, histone H3K4me3 and H3K9me3 were found highly over-methylated compared to normal muscle tissue.

CONCLUSION

Histone H3 lysine over-methylation may be a general basis of malignancy of the major sarcoma types.

摘要

背景/目的:肉瘤被认为是一种具有异质性的疾病,其分子基础尚未完全了解。在本研究中,为了进一步了解肉瘤的一般分子变化,建立了三种最常见的软组织肉瘤:黏液纤维肉瘤、未分化多形性肉瘤(UPS)和脂肪肉瘤的患者来源异种移植(PDX)小鼠模型,并研究了组蛋白 H3 赖氨酸标记的甲基化状态。

材料和方法

使用免疫印迹和免疫组织化学染色来定量组蛋白 H3K4me3 和组蛋白 H3K9me3 的甲基化程度。

结果

在 PDX 模型中的所有 3 种肉瘤类型中,与正常肌肉组织相比,组蛋白 H3K4me3 和 H3K9me3 被发现高度过度甲基化。

结论

组蛋白 H3 赖氨酸过度甲基化可能是主要肉瘤类型恶性肿瘤的一般基础。

相似文献

1
Over-methylation of Histone H3 Lysines Is a Common Molecular Change Among the Three Major Types of Soft-tissue Sarcoma in Patient-derived Xenograft (PDX) Mouse Models.组蛋白 H3 赖氨酸过度甲基化是患者来源异种移植(PDX)小鼠模型中三种主要软组织肉瘤的常见分子改变。
Cancer Genomics Proteomics. 2021 Nov-Dec;18(6):715-721. doi: 10.21873/cgp.20292.
2
Extent and Instability of Trimethylation of Histone H3 Lysine Increases With Degree of Malignancy and Methionine Addiction.组蛋白 H3 赖氨酸三甲基化的程度和不稳定性随恶性程度和蛋氨酸依赖性增加。
Cancer Genomics Proteomics. 2022 Jan-Feb;19(1):12-18. doi: 10.21873/cgp.20299.
3
Establishment and Characterization of Histologically and Molecularly Stable Soft-tissue Sarcoma Xenograft Models for Biological Studies and Preclinical Drug Testing.建立和鉴定组织学和分子学稳定的软组织肉瘤异种移植模型,用于生物学研究和临床前药物测试。
Mol Cancer Ther. 2019 Jun;18(6):1168-1178. doi: 10.1158/1535-7163.MCT-18-1045. Epub 2019 Apr 8.
4
Labeling the Stroma of a Patient-Derived Orthotopic Xenograft (PDOX) Mouse Model of Undifferentiated Pleomorphic Soft-Tissue Sarcoma With Red Fluorescent Protein for Rapid Non-Invasive Imaging for Drug Screening.用红色荧光蛋白标记未分化多形性软组织肉瘤患者来源的原位异种移植(PDOX)小鼠模型的基质,用于药物筛选的快速非侵入性成像。
J Cell Biochem. 2017 Feb;118(2):361-365. doi: 10.1002/jcb.25643. Epub 2016 Jul 12.
5
Assessment of the platelet-derived growth factor receptor alpha antibody olaratumab in a panel of patient-derived soft tissue sarcoma xenografts.评估血小板衍生生长因子受体 α 抗体奥拉单抗在一组患者来源的软组织肉瘤异种移植物中的作用。
BMC Cancer. 2019 Jul 22;19(1):724. doi: 10.1186/s12885-019-5872-1.
6
Histone H3 lysine 4 methyltransferase is required for facultative heterochromatin at specific loci.组蛋白 H3 赖氨酸 4 甲基转移酶对于特定基因座的兼性异染色质是必需的。
BMC Genomics. 2019 May 8;20(1):350. doi: 10.1186/s12864-019-5729-7.
7
Detection of Metastasis in a Patient-derived Orthotopic Xenograft (PDOX) Model of Undifferentiated Pleomorphic Sarcoma with Red Fluorescent Protein.在具有红色荧光蛋白的未分化多形性肉瘤患者来源原位异种移植(PDOX)模型中检测转移情况。
Anticancer Res. 2019 Jan;39(1):81-85. doi: 10.21873/anticanres.13082.
8
Histone H3K36 mutations promote sarcomagenesis through altered histone methylation landscape.组蛋白H3K36突变通过改变组蛋白甲基化格局促进肉瘤发生。
Science. 2016 May 13;352(6287):844-9. doi: 10.1126/science.aac7272.
9
Histone methylation status of H3K4me3 and H3K9me3 under methionine restriction is unstable in methionine-addicted cancer cells, but stable in normal cells.甲硫氨酸限制下 H3K4me3 和 H3K9me3 的组蛋白甲基化状态在甲硫氨酸成瘾性癌细胞中不稳定,但在正常细胞中稳定。
Biochem Biophys Res Commun. 2020 Dec 17;533(4):1034-1038. doi: 10.1016/j.bbrc.2020.09.108. Epub 2020 Oct 3.
10
Pdx-1 links histone H3-Lys-4 methylation to RNA polymerase II elongation during activation of insulin transcription.在胰岛素转录激活过程中,胰腺十二指肠同源盒-1(Pdx-1)将组蛋白H3赖氨酸-4甲基化与RNA聚合酶II延伸联系起来。
J Biol Chem. 2005 Oct 28;280(43):36244-53. doi: 10.1074/jbc.M505741200. Epub 2005 Sep 1.

引用本文的文献

1
Methionine Dependency and Restriction in Cancer: Exploring the Pathogenic Function and Therapeutic Potential.癌症中的甲硫氨酸依赖性与限制:探索致病功能和治疗潜力
Pharmaceuticals (Basel). 2025 Apr 28;18(5):640. doi: 10.3390/ph18050640.
2
Elevated-c-MYC-expressing Fibrosarcoma Cells With Acquired Gemcitabine Resistance Remain Sensitive to Recombinant Methioninase: A Potential Clinical Strategy for a Recalcitrant Disease.表达c-MYC且获得吉西他滨耐药性的纤维肉瘤细胞对重组蛋氨酸酶仍敏感:一种针对难治性疾病的潜在临床策略。
Cancer Diagn Progn. 2025 Jan 3;5(1):8-14. doi: 10.21873/cdp.10405. eCollection 2025 Jan-Feb.
3
Synergistic Eradication of Fibrosarcoma With Acquired Ifosfamide Resistance Using Methionine Restriction Combined With Ifosfamide in Nude-mouse Models.在裸鼠模型中使用蛋氨酸限制联合异环磷酰胺协同根除具有获得性异环磷酰胺耐药性的纤维肉瘤
In Vivo. 2025 Jan-Feb;39(1):120-126. doi: 10.21873/invivo.13809.
4
Targeting Methionine Addiction Combined With Low-dose Irinotecan Arrested Colon Cancer in Contrast to High-dose Irinotecan Alone, Which Was Ineffective, in a Nude-mouse Model.在裸鼠模型中,与单独使用高剂量伊立替康相比,靶向蛋氨酸成瘾联合低剂量伊立替康可有效抑制结直肠癌,而高剂量伊立替康则无效。
In Vivo. 2024 May-Jun;38(3):1058-1063. doi: 10.21873/invivo.13539.
5
Extensive Shrinkage and Long-term Stable Disease in a Teenage Female Patient With High-grade Glioma Treated With Temozolomide and Radiation in Combination With Oral Recombinant Methioninase and a Low-methionine Diet.替莫唑胺联合放疗联合口服重组甲硫氨酸酶和低甲硫氨酸饮食治疗高级别胶质瘤的青少年女性患者的广泛退缩和长期稳定疾病。
In Vivo. 2024 May-Jun;38(3):1459-1464. doi: 10.21873/invivo.13591.
6
Genetic, Epigenetic and Transcriptome Alterations in Liposarcoma for Target Therapy Selection.用于靶向治疗选择的脂肪肉瘤中的遗传、表观遗传和转录组改变
Cancers (Basel). 2024 Jan 8;16(2):271. doi: 10.3390/cancers16020271.
7
Asymmetric and symmetric protein arginine methylation in methionine-addicted human cancer cells.甲硫氨酸成瘾的人类癌细胞中的非对称和对称蛋白精氨酸甲基化。
PLoS One. 2023 Dec 22;18(12):e0296291. doi: 10.1371/journal.pone.0296291. eCollection 2023.
8
The Combination of Methioninase and Ethionine Exploits Methionine Addiction to Selectively Eradicate Osteosarcoma Cells and Not Normal Cells and Synergistically Down-regulates the Expression of .蛋氨酸酶和乙硫氨酸联合利用蛋氨酸成瘾选择性消除骨肉瘤细胞而不杀伤正常细胞,并协同下调表达。
Cancer Genomics Proteomics. 2023 Dec;20(6suppl):679-685. doi: 10.21873/cgp.20415.
9
Recombinant-methioninase-producing Instilled in the Microbiome Inhibits Triple-negative Breast Cancer in an Orthotopic Cell-line Mouse Model.在原位细胞系小鼠模型中,向微生物群中注入产重组蛋氨酸酶的物质可抑制三阴性乳腺癌。
Cancer Diagn Progn. 2023 Nov 3;3(6):649-654. doi: 10.21873/cdp.10267. eCollection 2023 Nov-Dec.
10
Recombinant Methioninase Lowers the Effective Dose of Regorafenib Against Colon-Cancer Cells: A Strategy for Widespread Clinical Use of a Toxic Drug.重组甲硫氨酸酶降低瑞戈非尼对结肠癌细胞的有效剂量:一种有毒药物广泛临床应用的策略。
Cancer Diagn Progn. 2023 Nov 3;3(6):655-659. doi: 10.21873/cdp.10268. eCollection 2023 Nov-Dec.

本文引用的文献

1
Oral-recombinant Methioninase Converts an Osteosarcoma from Docetaxel-resistant to -Sensitive in a Clinically-relevant Patient-derived Orthotopic-xenograft (PDOX) Mouse Model.口服重组蛋氨酸酶在临床相关的患者源性原位异种移植(PDOX)小鼠模型中,可将骨肉瘤从多西他赛耐药转变为敏感。
Anticancer Res. 2021 Apr;41(4):1745-1751. doi: 10.21873/anticanres.14939.
2
Lipid remodeling in response to methionine stress in MDA-MBA-468 triple-negative breast cancer cells.丙氨酰-苏氨酰-天门冬酰-赖氨酰-脯氨酸对 MDA-MBA-468 三阴性乳腺癌细胞迁移和侵袭的影响及机制研究
J Lipid Res. 2021;62:100056. doi: 10.1016/j.jlr.2021.100056. Epub 2021 Feb 26.
3
Combination Methionine-methylation-axis Blockade: A Novel Approach to Target the Methionine Addiction of Cancer.联合甲硫氨酸甲基化轴阻断:一种针对癌症甲硫氨酸成瘾的新方法。
Cancer Genomics Proteomics. 2021 Mar-Apr;18(2):113-120. doi: 10.21873/cgp.20246.
4
Sensing and Signaling of Methionine Metabolism.甲硫氨酸代谢的感知与信号传导
Metabolites. 2021 Jan 31;11(2):83. doi: 10.3390/metabo11020083.
5
Histone methylation status of H3K4me3 and H3K9me3 under methionine restriction is unstable in methionine-addicted cancer cells, but stable in normal cells.甲硫氨酸限制下 H3K4me3 和 H3K9me3 的组蛋白甲基化状态在甲硫氨酸成瘾性癌细胞中不稳定,但在正常细胞中稳定。
Biochem Biophys Res Commun. 2020 Dec 17;533(4):1034-1038. doi: 10.1016/j.bbrc.2020.09.108. Epub 2020 Oct 3.
6
Recombinant Methioninase Combined With Tumor-targeting A1-R Induced Regression in a PDOX Mouse Model of Doxorubicin-resistant Dedifferentiated Liposarcoma.重组甲硫氨酸酶联合肿瘤靶向 A1-R 诱导多柔比星耐药去分化脂肪肉瘤 PDOX 小鼠模型的消退。
Anticancer Res. 2020 May;40(5):2515-2523. doi: 10.21873/anticanres.14222.
7
Methionine Dependence of Cancer.癌症的蛋氨酸依赖性。
Biomolecules. 2020 Apr 8;10(4):568. doi: 10.3390/biom10040568.
8
Combination of oral recombinant methioninase and decitabine arrests a chemotherapy-resistant undifferentiated soft-tissue sarcoma patient-derived orthotopic xenograft mouse model.口服重组甲硫氨酸酶和地西他滨联合治疗耐药性未分化软组织肉瘤患者来源的原位异种移植小鼠模型。
Biochem Biophys Res Commun. 2020 Feb 26;523(1):135-139. doi: 10.1016/j.bbrc.2019.12.024. Epub 2019 Dec 12.
9
The combination of oral-recombinant methioninase and azacitidine arrests a chemotherapy-resistant osteosarcoma patient-derived orthotopic xenograft mouse model.口服重组甲硫氨酸酶联合阿扎胞苷可抑制化疗耐药骨肉瘤患者来源的原位异种移植小鼠模型。
Cancer Chemother Pharmacol. 2020 Feb;85(2):285-291. doi: 10.1007/s00280-019-03986-0. Epub 2019 Nov 8.
10
Patient-derived orthotopic xenograft models of sarcoma.患者来源的肉瘤原位异种移植模型。
Cancer Lett. 2020 Jan 28;469:332-339. doi: 10.1016/j.canlet.2019.10.028. Epub 2019 Oct 19.